Skip to content
10-Q

Quarterly Report

Xilio Therapeutics, Inc. XLO

0001193125-25-278837

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 52.5M sh
Capex Q3 2025 · Sep 30, 2025 $423K
Capex Q3 2025 · Sep 30, 2024 $30K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.99M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$4.22M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $103.76M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $55.29M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $61.26M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$8.1M
Stockholders Equity Q3 2025 · Jun 30, 2025 $7.07M
Stockholders Equity Q3 2025 · Dec 31, 2024 $17.6M
Stockholders Equity Q3 2025 · Sep 30, 2024 $20.97M
Stockholders Equity Q3 2025 · Jun 30, 2024 $33.42M
Stockholders Equity Q3 2025 · Dec 31, 2023 $36.83M
Current Liabilities Q3 2025 · Sep 30, 2025 $56.4M
Current Liabilities Q3 2025 · Dec 31, 2024 $27.26M
Total Liabilities Q3 2025 · Sep 30, 2025 $141.79M
Total Liabilities Q3 2025 · Dec 31, 2024 $53.48M
Current Assets Q3 2025 · Sep 30, 2025 $124.09M
Current Assets Q3 2025 · Dec 31, 2024 $60.23M
Total Assets Q3 2025 · Sep 30, 2025 $133.69M
Total Assets Q3 2025 · Dec 31, 2024 $71.08M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.43
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.91
Eps Basic Q3 2025 · Sep 30, 2025 −$0.11
Eps Basic Q3 2025 · Sep 30, 2025 −$0.43
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2024 −$0.91
Sga Expense Q3 2025 · Sep 30, 2025 $6.67M
Sga Expense Q3 2025 · Sep 30, 2025 $22.31M
Sga Expense Q3 2025 · Sep 30, 2024 $6.31M
Sga Expense Q3 2025 · Sep 30, 2024 $18.26M
Rd Expense Q3 2025 · Sep 30, 2025 $14.32M
Rd Expense Q3 2025 · Sep 30, 2025 $37.92M
Rd Expense Q3 2025 · Sep 30, 2024 $10.76M
Rd Expense Q3 2025 · Sep 30, 2024 $32.38M
Net Income Q3 2025 · Sep 30, 2025 −$16.29M
Net Income Q3 2025 · Sep 30, 2025 −$45.4M
Net Income Q3 2025 · Sep 30, 2024 −$14.02M
Net Income Q3 2025 · Sep 30, 2024 −$45.15M
Operating Income Q3 2025 · Sep 30, 2025 −$1.93M
Operating Income Q3 2025 · Sep 30, 2025 −$30.15M
Operating Income Q3 2025 · Sep 30, 2024 −$14.76M
Operating Income Q3 2025 · Sep 30, 2024 −$46.95M
Revenue Q3 2025 · Sep 30, 2025 $19.07M
Revenue Q3 2025 · Sep 30, 2025 $30.08M
Revenue Q3 2025 · Sep 30, 2024 $2.26M
Revenue Q3 2025 · Sep 30, 2024 $4.62M